Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound

Chun Han Lin, Tiina Jokela, Joe Gray, Mark A. LaBarge

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four cancer cell lines. Combinations of ECM and soluble factors were printed on stiffness-tunable substrata to generate a collection of controlled microenvironments in which to explore cell-based functional responses. Proliferation, HER2 protein expression and phosphorylation, and morphology were measured in single cells. Using dimension reduction and linear modeling, the effects of microenvironment constituents were identified and then validated empirically. Each of the cell lines exhibits unique microenvironment-response patterns. Fibronectin, type IV collagen, and matrix rigidity are significant regulators of lapatinib resistance in HER2-amplified breast cancer cells. Small-molecule inhibitors were identified that could attenuate microenvironment-imposed resistance. Thus, we demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments to improve the efficacy of anti-cancer therapeutics. Tumor microenvironments are a driver of anti-cancer drug resistance. Lin et al. use microenvironment microarrays and a cell-based functional approach to identify microenvironment components that modulate lapatinib responses in isogenic cells. They demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments that may improve the understanding and efficacy of anti-cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)533-545
Number of pages13
JournalCell Reports
Volume21
Issue number2
DOIs
StatePublished - Oct 10 2017

Fingerprint

Tumors
Cells
Tumor Microenvironment
Military electronic countermeasures
Neoplasms
Phosphorylation
Collagen Type IV
Microarrays
Fibronectins
Rigidity
Pharmaceutical Preparations
Cellular Microenvironment
Cell Line
Stiffness
Molecules
Drug Resistance
Cell Communication
lapatinib
Breast Neoplasms
Proteins

Keywords

  • AZD0530
  • breast cancer
  • drug resistance
  • fibronectin
  • HER2
  • lapatinib
  • MEMA
  • microenvironment
  • microenvironment microarray
  • verteporfin
  • YAP

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound. / Lin, Chun Han; Jokela, Tiina; Gray, Joe; LaBarge, Mark A.

In: Cell Reports, Vol. 21, No. 2, 10.10.2017, p. 533-545.

Research output: Contribution to journalArticle

@article{7f528592e8aa42f3bc057399a1195737,
title = "Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound",
abstract = "Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four cancer cell lines. Combinations of ECM and soluble factors were printed on stiffness-tunable substrata to generate a collection of controlled microenvironments in which to explore cell-based functional responses. Proliferation, HER2 protein expression and phosphorylation, and morphology were measured in single cells. Using dimension reduction and linear modeling, the effects of microenvironment constituents were identified and then validated empirically. Each of the cell lines exhibits unique microenvironment-response patterns. Fibronectin, type IV collagen, and matrix rigidity are significant regulators of lapatinib resistance in HER2-amplified breast cancer cells. Small-molecule inhibitors were identified that could attenuate microenvironment-imposed resistance. Thus, we demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments to improve the efficacy of anti-cancer therapeutics. Tumor microenvironments are a driver of anti-cancer drug resistance. Lin et al. use microenvironment microarrays and a cell-based functional approach to identify microenvironment components that modulate lapatinib responses in isogenic cells. They demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments that may improve the understanding and efficacy of anti-cancer therapeutics.",
keywords = "AZD0530, breast cancer, drug resistance, fibronectin, HER2, lapatinib, MEMA, microenvironment, microenvironment microarray, verteporfin, YAP",
author = "Lin, {Chun Han} and Tiina Jokela and Joe Gray and LaBarge, {Mark A.}",
year = "2017",
month = "10",
day = "10",
doi = "10.1016/j.celrep.2017.09.058",
language = "English (US)",
volume = "21",
pages = "533--545",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound

AU - Lin, Chun Han

AU - Jokela, Tiina

AU - Gray, Joe

AU - LaBarge, Mark A.

PY - 2017/10/10

Y1 - 2017/10/10

N2 - Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four cancer cell lines. Combinations of ECM and soluble factors were printed on stiffness-tunable substrata to generate a collection of controlled microenvironments in which to explore cell-based functional responses. Proliferation, HER2 protein expression and phosphorylation, and morphology were measured in single cells. Using dimension reduction and linear modeling, the effects of microenvironment constituents were identified and then validated empirically. Each of the cell lines exhibits unique microenvironment-response patterns. Fibronectin, type IV collagen, and matrix rigidity are significant regulators of lapatinib resistance in HER2-amplified breast cancer cells. Small-molecule inhibitors were identified that could attenuate microenvironment-imposed resistance. Thus, we demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments to improve the efficacy of anti-cancer therapeutics. Tumor microenvironments are a driver of anti-cancer drug resistance. Lin et al. use microenvironment microarrays and a cell-based functional approach to identify microenvironment components that modulate lapatinib responses in isogenic cells. They demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments that may improve the understanding and efficacy of anti-cancer therapeutics.

AB - Tumor microenvironments are a driver of resistance to anti-cancer drugs. Dissecting cell-microenvironment interactions into tractable units of study presents a challenge. Here, we assess the impact of hundreds of tumor-inspired microenvironments, in parallel, on lapatinib responses in four cancer cell lines. Combinations of ECM and soluble factors were printed on stiffness-tunable substrata to generate a collection of controlled microenvironments in which to explore cell-based functional responses. Proliferation, HER2 protein expression and phosphorylation, and morphology were measured in single cells. Using dimension reduction and linear modeling, the effects of microenvironment constituents were identified and then validated empirically. Each of the cell lines exhibits unique microenvironment-response patterns. Fibronectin, type IV collagen, and matrix rigidity are significant regulators of lapatinib resistance in HER2-amplified breast cancer cells. Small-molecule inhibitors were identified that could attenuate microenvironment-imposed resistance. Thus, we demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments to improve the efficacy of anti-cancer therapeutics. Tumor microenvironments are a driver of anti-cancer drug resistance. Lin et al. use microenvironment microarrays and a cell-based functional approach to identify microenvironment components that modulate lapatinib responses in isogenic cells. They demonstrate a strategy to identify resistance- and sensitivity-driving microenvironments that may improve the understanding and efficacy of anti-cancer therapeutics.

KW - AZD0530

KW - breast cancer

KW - drug resistance

KW - fibronectin

KW - HER2

KW - lapatinib

KW - MEMA

KW - microenvironment

KW - microenvironment microarray

KW - verteporfin

KW - YAP

UR - http://www.scopus.com/inward/record.url?scp=85030858549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030858549&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2017.09.058

DO - 10.1016/j.celrep.2017.09.058

M3 - Article

C2 - 29020637

AN - SCOPUS:85030858549

VL - 21

SP - 533

EP - 545

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 2

ER -